UK Drug Safety Update · February 05, 2026

Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Non-arteritic anterior ischemic optic neuropathy (NAION) has been very rarely reported with semaglutide treatment.

Low obligation Product class Pharmaceuticals UK Pharmacovigilance

Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatmen…

Read the official source ↗

Published by UK Drug Safety Update. HealthSignal links to the original document; the summary above is extracted from the source text.